Inflammatory Cytokines and Cognition in Alzheimer’s Disease and Its Prodrome
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The aim of this study was to investigate the association between blood levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and cognitive impairments among elderly individuals.Methods Peripheral concentration of TNF-α and IL-6 were measured in all subjects. To assess individual cognitive function, the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-NP) was used, and standardized scores (z-scores) were calculated for each test. Cytokine levels were compared between the diagnostic groups, and correlations between blood inflammatory factor levels and z-scores were analyzed.Results The 37 participants included 8 patients with Alzheimer’s disease (AD), 15 subjects with mild cognitive impairment (MCI), and 14 cognitively healthy controls. TNF-α and IL-6 levels were higher in patients with AD than in healthy controls. TNF-α levels were higher in the AD group than in the MCI group. However, after adjusting for age, the associations between diagnosis and TNF-α and IL-6 were not significant. The higher the plasma IL-6 level, the lower the z-scores on the Boston Naming Test, Word List Learning, Word List Recognition, and Constructional Recall. The higher the serum TNF-α level, the lower the z-scores on the Word List Learning and Constructional Recall. Negative correlation between serum TNF-α level and the z-score on Word List Learning remained significant when age was adjusted.Conclusion The difference in the blood levels of TNF-α and IL-6 between the diagnostic groups may be associated with aging. However, elevated TNF-α levels were associated with worse immediate memory performance, even after adjusting for age.
Abstract
Objective The aim of this study was to investigate the association between blood levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and cognitive impairments among elderly individuals.Methods Peripheral concentration of TNF-α and IL-6 were measured in all subjects. To assess individual cognitive function, the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-NP) was used, and standardized scores (z-scores) were calculated for each test. Cytokine levels were compared between the diagnostic groups, and correlations between blood inflammatory factor levels and z-scores were analyzed.Results The 37 participants included 8 patients with Alzheimer’s disease (AD), 15 subjects with mild cognitive impairment (MCI), and 14 cognitively healthy controls. TNF-α and IL-6 levels were higher in patients with AD than in healthy controls. TNF-α levels were higher in the AD group than in the MCI group. However, after adjusting for age, the associations between diagnosis and TNF-α and IL-6 were not significant. The higher the plasma IL-6 level, the lower the z-scores on the Boston Naming Test, Word List Learning, Word List Recognition, and Constructional Recall. The higher the serum TNF-α level, the lower the z-scores on the Word List Learning and Constructional Recall. Negative correlation between serum TNF-α level and the z-score on Word List Learning remained significant when age was adjusted.Conclusion The difference in the blood levels of TNF-α and IL-6 between the diagnostic groups may be associated with aging. However, elevated TNF-α levels were associated with worse immediate memory performance, even after adjusting for age.
참고문헌 (68)
- Alzheimer’s Association, "2022 Alzheimer’s disease facts and figures", Alzheimers Dement, 18, pp.700~789 (2022)
- Gouras GK, "The inside-out amyloid hypothesis and synapse pathology in Alzheimer’s disease", Neurodegener Dis, 13, pp.142~146 (2014)
- Kent SA, "The physiological roles of tau and Aβ : implications for Alzheimer’s disease pathology and therapeu tics", Acta Neuropathol, 140, pp.417~447 (2020)
- Jorfi M, "The neuroimmune axis of Al zheimer’s disease", Genome Med, 15, pp.6~ (2023)
- Heneka MT, "Neuroinflammation in Alzheimer’s disease", Lancet Neurol, 14, pp.388~405 (2015)
- McCaulley ME, "Alzheimer’s disease : exploring the role of inflammation and implications for treatment", Int J Alzheimers Dis, 2015, pp.515248~ (2015)
- Hanzel CE, "Neuronal driven pre-plaque inflammation in a trans genic rat model of Alzheimer’s disease", Neurobiol Aging, 35, pp.22492262~ (2014)
- Ferretti MT, "Intra cellular Aβ-oligomers and early inflammation in a model of Alzheim er’s disease", Neurobiol Aging, 33, pp.1329~1342 (2012)
- McAlpine FE, "Inhibition of soluble TNF signaling in a mouse model of Alzheim er’s disease prevents pre-plaque amyloid-associated neuropathology", Neurobiol Dis, 34, pp.163~177 (2009)
- Cavanagh C, "Inhibiting tumor necrosis factor-α before amyloidosis prevents syn aptic deficits in an Alzheimer’s disease model", Neurobiol Aging, 47, pp.41~49 (2016)
- Leira Y, "Is periodontal disease associated with Alzheimer’s disease? A systematic review with meta-analysis", Neuroepidemiology, 48, pp.21~31 (2017)
- Trenova AG, "A role of cytokine gene polymorphisms in cognitive functioning", Folia Med(Plovdiv), 60, pp.191~199 (2018)
- Stacey D, "A systematic review on the association between inflammatory genes and cognitive decline in non-de mented elderly individuals", Eur Neuropsychopharmacol, 27, pp.568588~ (2017)
- Su F, "Inflammatory cytokines and Alzheimer’s disease : a review from the perspective of genetic polymorphisms", Neurosci Bull, 32, pp.469~480 (2016)
- Shen Z, "Clinical PET imaging of microglial activation : implications for microglial therapeutics in Alzheimer’s disease", Front Aging Neurosci, 10, pp.314~ (2018)
- Tondo G, "The combined effects of microglia activation and brain glu cose hypometabolism in early-onset Alzheimer’s disease", Alzheimers Res Ther, 12, pp.50~ (2020)
- Chai YL, "Inflammatory panel cytokines are elevated in the neocortex of late stage Alzheimer’s disease but not Lewy body dementias", J Neuroinflammation, 20, pp.111~ (2023)
- Lyra E Silva NM, "Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Al zheimer’s disease", Transl Psychiatry, 11, pp.251~ (2021)
- Leng F, "Neuroinflammation and microglial activation in Al zheimer disease : where do we go from here?", Nat Rev Neurol, 17, pp.157~172 (2021)
- Si ZZ, "Targeting neuroin f lammation in Alzheimer’s disease : from mechanisms to clinical appli cations", Neural Regen Res, 18, pp.708~715 (2023)
- Ghosh P, "Cellular and molecular influencers of neuroinflammation in Al zheimer’s disease : recent concepts & roles", Neurochem Int, 151, pp.105212~ (2021)
- Bronzuoli MR, "Targeting neuroin f lammation in Alzheimer’s disease", J Inflamm Res, 9, pp.199~208 (2016)
- Ismail R, "The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease : a longitudinal PET study", J Neuroinflammation, 17, pp.151~ (2020)
- Parbo P, "Brain inflammation accompanies amyloid in the majority of mild cog nitive impairment cases due to Alzheimer’s disease", Brain, 140, pp.2002~2011 (2017)
- Pagoni P, "Causal effects of circulating cytokine con centrations on risk of Alzheimer’s disease and cognitive function", Brain Behav Immun, 104, pp.54~64 (2022)
- Newcombe EA, "Inflammation : the link between comorbidities, genetics, and Alzheimer’s disease", J Neuroinflammation, 15, pp.276~ (2018)
- McAfoose J, "Evidence for a cytokine model of cognitive function", Neurosci Biobehav Rev, 33, pp.355~366 (2009)
- Yirmiya R, "Immune modulation of learning, memory, neural plasticity and neurogenesis", Brain Behav Immun, 25, pp.181~213 (2011)
- Jin R, "Relationships between inflammation and age-related neurocognitive changes", Int J Mol Sci, 23, pp.12573~ (2022)
- Tanaka T, "IL-6 in inflammation, immunity, and disease", Cold Spring Harb Perspect Biol, 6, pp.a016295~ (2014)
- Shen XN, "Inflammatory markers in Alzheimer’s disease and mild cognitive impairment : a me ta-analysis and systematic review of 170 studies", J Neurol Neurosurg Psychiatry, 90, pp.590~598 (2019)
- Bruunsgaard H, "A high plasma concentration of TNF-α is associated with dementia in centenarians", J Gerontol A Biol Sci Med Sci, 54, pp.M357~M364 (1999)
- Lombardi VR, "Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer’s disease(AD)individuals", J Neuroimmunol, 97, pp.163~171 (1999)
- Ray S, "Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins", Nat Med, 13, pp.1359~1362 (2007)
- Fard MT, "Peripheral inflammation marker re lationships to cognition in healthy older adults – A systematic review", Psychoneuroendocrinology, 144, pp.105870~ (2022)
- McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s dis ease", Alzheimers Dement, 7, pp.263~269 (2011)
- Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Al zheimer’s Association workgroups on diagnostic guidelines for Al zheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
- Morris JC, "The Consortium to Establish a Registry for Alzheimer’s Disease(CERAD). Part I. Clinical and neuropsychological assessment of Al zheimer’s disease", Neurology, 39, pp.1159~1165 (1989)
- Lee JH, "Develop ment of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
- Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly", J Int Neuropsychol Soc, 10, pp.72~81 (2004)
- Welsh KA, "The Consortium to Establish a Registry for Alzheimer’s Disease(CERAD). Part V. A normative study of the neuropsychological battery", Neurology, 44, pp.609~614 (1994)
- Han JY, "A norma tive study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population", Int Psychogeri atr, 26, pp.1897~1904 (2014)
- Swanson A, "Neuroinflammation in Alzheimer’s disease : pleiotropic roles for cytokines and neuronal pen traxins", Behav Brain Res, 347, pp.49~56 (2018)
- Pan W, "Tumor necrosis factor-α : a neuromodulator in the CNS", Neurosci Biobehav Rev, 21, pp.603~613 (1997)
- Leonardo S, "Association of inflammation and cognition in the elderly : a systematic review and meta-analysis", Front Aging Neurosci, 15, pp.1069439~ (2023)
- Capogna E, "Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers – in cognitively un impaired older adults", Brain Behav Immun, 113, pp.56~65 (2023)
- Wennberg AMV, "The cross-sectional and longitudinal associations be tween IL-6, IL-10, and TNFα and cognitive outcomes in the Mayo Clinic Study of Aging", J Gerontol A Biol Sci Med Sci, 74, pp.1289~1295 (2019)
- Trapero I, "Interleukin 6 and cognitive dysfunction", Metab Brain Dis, 29, pp.593~608 (2014)
- Misiak B, "Cytokines and C-reactive protein alterations with re spect to cognitive impairment in schizophrenia and bipolar disorder : a systematic review", Schizophr Res, 192, pp.16~29 (2018)
- Patlola SR, "The relationship between in flammatory biomarkers and cognitive dysfunction in patients with schizophrenia : a systematic review and meta-analysis", Prog Neuropsychopharmacol Biol Psychiatry, 121, pp.110668~ (2023)
- Kulesh A, "Cytokine response, tract-specific fractional anisotropy, and brain morphometry in post-stroke cognitive impairment", J Stroke Cerebrovasc Dis, 27, pp.1752~1759 (2018)
- Nuber-Champier A, "Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection", Psychoneuroendocrinology, 153, pp.106104~ (2023)
- Koelman L, "Cytokines for evaluation of chronic inflammatory status in ageing research : reliability and phenotypic characterisation", Immun Ageing, 16, pp.11~ (2019)
- Stevenson AJ, "Trajectories of inflammatory biomarkers over the eighth de cade and their associations with immune cell profiles and epigenetic ageing", Clin Epigenetics, 10, pp.159~ (2018)
- Lim A, "Peripheral inflammation and cognitive aging", Mod Trends Pharmacopsychiatry, 28, pp.175~187 (2013)
- Shao Z, "What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults", Front Psychol, 5, pp.772~ (2014)
- Flores-Aguilar L, "Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition", J Neuroinflammation, 18, pp.147~ (2021)
- Karoly HC, "Investigat ing associations between inflammatory biomarkers, gray matter, neuro f ilament light and cognitive performance in healthy older adults", Front Aging Neurosci, 13, pp.719553~ (2021)
- Marsland AL, "Systemic inflammation and resting state connectivity of the de fault mode network", Brain Behav Immun, 62, pp.162~170 (2017)
- Dev SI, "Peripheral inflammation related to lower fMRI activation during a work ing memory task and resting functional connectivity among older adults : a preliminary study", Int J Geriatr Psychiatry, 32, pp.341~349 (2017)
- Teoh NSN, "Association of interleukin-6 and interleukin-8 with cognitive decline in an Asian memory clinic population", J Alzheimers Dis, 92, pp.445~455 (2023)
- Baune BT, "Association between IL-8 cytokine and cognitive performance in an elderly general population--the MEMO-study", Neurobiol Aging, 29, pp.937~944 (2008)
- Tegeler C, "The inflammatory markers CRP, IL-6, and IL-10are associated with cognitive function—data from the Berlin Aging Study II", Neurobiol Aging, 38, pp.112~117 (2016)
- Trollor JN, "T he association between systemic inflammation and cognitive perfor mance in the elderly : the Sydney Memory and Ageing Study", Age(Dor dr), 34, pp.1295~1308 (2012)
- Schram MT, "Systemic markers of inflammation and cognitive decline in old age", J Am Geriatr Soc, 55, pp.708~716 (2007)
- Alley DE, "Inflam mation and rate of cognitive change in high-functioning older adults", J Gerontol A Biol Sci Med Sci, 63, pp.50~55 (2008)
- Economos A, "Interleukin 6 plasma concentration associates with cognitive de cline : the northern Manhattan study", Neuroepidemiology, 40, pp.253~259 (2013)
- Chi GC, "Inflammatory biomarkers predict domain-specific cognitive decline in older adults", J Gerontol A Biol Sci Med Sci, 72, pp.796~803 (2017)